Investigator-initiated Trials

Celgene is committed to enhancing clinical and translational research in diseases related to the current and future areas of interest of the company. Celgene considers requests for support of investigator-initiated research in these therapy areas. The mission and purpose of the research program is to support investigators who have ideas to use Celgene compounds to obtain new knowledge that could advance our understanding of a specific drug and contribute to an improvement in the care of patients.

For further information, please contact ANZ Celgene Medical Information on 1800 235 436 (option 3) or via email: medinfo.au@celgene.com